Picture of Accrol group logo

ACRL Accrol group News Story

0.000.00%
gb flag iconLast trade - 00:00
Consumer DefensivesAdventurousSmall CapTurnaround

RCS - Accrol Group Hldgs - Online Investor Presentation




 



RNS Number : 6213I
Accrol Group Holdings PLC
15 December 2020
 

RNS Reach

 

15 December 2020

 

ACCROL GROUP HOLDINGS PLC
("Accrol" or the "Group")

AIM: ACRL

 

ONLINE INVESTOR PRESENTATION

 

Accrol Group, one of the UK's leading independent tissue converters, is pleased to announce that following the successful acquisition of Leicester Tissue Company ("LTC") in November 2020, the Group's CEO senior management team is hosting a presentation to provide retail investors with background on Accrol, the Board's strategy and ambitions and the rationale for the acquisition of LTC.

 

The webinar will take place at 2.00pm today, 15 December 2020, via Zoom.

 

If you would like to join the webinar, please email georgina@melloevents.com, who will provide login details. 

 

For further information, please contact:

 

 

 

Accrol Group Holdings plc

 

Dan Wright, Executive Chairman

Via Belvedere Communications

Gareth Jenkins, Chief Executive Officer

 

 

 

Zeus Capital Limited (Nominated Adviser & Broker) 

 

Dan Bate / Jordan Warburton

Tel: +44 (0) 161 831 1512

Dominic King / John Goold

Tel: +44 (0) 203 829 5000

 

 

Liberum Capital Limited (Joint Broker)

Tel: +44 (0) 20 3100 2222

Clayton Bush / Edward Thomas

 

 

 

Belvedere Communications Limited

 

Cat Valentine

Tel: +44 (0) 7715 769 078

Keeley Clarke

Tel: +44 (0) 7967 816 525

Llew Angus

Tel:  +44 (0) 7407 023 147

 

accrolpr@belvederepr.com

 

Overview of Accrol

 

Accrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls and facial tissues to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisition of a state-of-the-art tissue converter based in Leicester, the Group now operates from five sites, including four in Lancashire, which generate revenues totalling c.16% of the £1.7bn UK retail tissue market.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABIBDDIDBDGGS

Recent news on Accrol group

See all news